Based on the Oncology Institute Inc stock forecast from 0 analysts, the average analyst target price for Oncology Institute Inc is not available over the next 12 months. Oncology Institute Inc’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Oncology Institute Inc is Very Bearish, which is based on 0 positive signals and 9 negative signals. At the last closing, Oncology Institute Inc’s stock price was USD 0.60. Oncology Institute Inc’s stock price has changed by +61.75% over the past week, +184.77% over the past month and -72.04% over the last year.
No recent analyst target price found for Oncology Institute Inc
No recent average analyst rating found for Oncology Institute Inc
Company Overview Oncology Institute Inc
The Oncology Institute, Inc., an oncology company, provides various medical oncology services in the United States. The company operates through three segments: Dispensary, Patient Services, and Clinical Trials & Other. It offers physician services, in-house infusion and dispensary, clinical trial, radiation, outpatient blood product transfusion, and patient support services, as well as educational seminars, support groups, and counseling services. The company also provides managing clinical trials, palliative care programs, stem cell transplants services, and other care delivery models associated with non-community-based academic and tertiary care settings; and conducts clinical trials for a range of pharmaceutical and medical device companies. It serves adult and senior cancer patients. The company has a strategic collaboration with Healthly Forge to offer cancer care services to patients in Southern California. The Oncology Institute, Inc. was founded in 2007 and is headquartered in Cerritos, California. Read Less
The Oncology Institute, Inc., an oncology company, provides various medical oncology services in the United States. The company operates through three segments: Dispensary, Patient Services, and Clinical Trials & Other. It offers physician services, in-house infusion and dispensa...Read More
Frequently Asked Questions About Oncology Institute Inc (TOI) Stock
Stock Target Advisor's fundamental analysis for Oncology Institute Inc's stock is Very Bearish.
Unfortunately we do not have enough data on TOI's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on TOI's stock to indicate what its average analyst target is.
TOI stock's Price/Earning ratio is 48.33.
Our analysis grades TOI stock's Price / Earning ratio at F. This means that TOI stock's Price/Earning ratio is above 69% of the stocks in the Medical Care Facilities sector in the NSD exchange.
Based on this TOI may be a overvalued for its sector.
The last closing price of TOI's stock was USD 0.60.
The most recent market capitalization for TOI is USD 0.02B.
Unfortunately we do not have enough analyst data on TOI's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Oncology Institute Inc's stock.
As per our most recent records Oncology Institute Inc has 800 Employees.
Oncology Institute Inc's registered address is 18000 Studebaker Road, Cerritos, CA, United States, 90703.
You can get more information about it from Oncology Institute Inc's website at https://theoncologyinstitute.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
There is nothing we particularly like
What not to like
Overpriced compared to earnings
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Low market capitalization
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
Negative cashflow
The company had negative total cash flow in the most recent four quarters.
Negative free cash flow
The company had negative total free cash flow in the most recent four quarters.
Low Earnings Growth
This stock has shown below median earnings growth in the previous 5 years compared to its sector
Highly leveraged
The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.
Frequently Asked Questions About Oncology Institute Inc (TOI) Stock
Stock Target Advisor's fundamental analysis for Oncology Institute Inc's stock is Very Bearish.
Unfortunately we do not have enough data on TOI's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on TOI's stock to indicate what its average analyst target is.
TOI stock's Price/Earning ratio is 48.33.
Our analysis grades TOI stock's Price / Earning ratio at F. This means that TOI stock's Price/Earning ratio is above 69% of the stocks in the Medical Care Facilities sector in the NSD exchange.
Based on this TOI may be a overvalued for its sector.
The last closing price of TOI's stock was USD 0.60.
The most recent market capitalization for TOI is USD 0.02B.
Unfortunately we do not have enough analyst data on TOI's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Oncology Institute Inc's stock.
As per our most recent records Oncology Institute Inc has 800 Employees.
Oncology Institute Inc's registered address is 18000 Studebaker Road, Cerritos, CA, United States, 90703.
You can get more information about it from Oncology Institute Inc's website at https://theoncologyinstitute.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for TOI !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
